Antineoplastic agents in melanoma-related clinical t rials (september 2008) - Composés antinéoplasiques en essa is cliniques relatifs au mélanome (septembre 2008)

Antineoplastic agents in melanoma-related clinical trials (september
2008) - Composés antinéoplasiques en essais cliniques relatifs au
mélanome (septembre 2008)



Aldesleukin, Alemtuzumab, Arsenic trioxide, Azacitidine

Betulinic acid, Bevacizumab, Bleomycin, Bortezomib, Bryostatin 1,
Busulfan, Buthionine Sulfoximine

Camptothecin, Carboxyamido-triazole, Carmustine,  Cyclophosphamide

Dacarbazine, Dactinomycin, Decitabine, Denileukin diftitox,
Dexamethasone, Docetaxel, Doxorubicin

Epirubicin, Epothilone B, Epothilones, Etoposide, Etoposide phosphate

Fenretinide, Flavopiridol, Fludarabine, Fludarabine monophosphate,
Fotemustine, FR 901228

Gemcitabine, Genistein

Ifosfamide, Imatinib, Imiquimod, Interferon Alfa-2a, Interferon
Alfa-2b, Interferon Type I (Recombinant), Irinotecan, Irofulven,
Isophosphamide mustard

Lenalidomide, Leuprolide, Lomustine

Mechlorethamine, Melphalan, Methotrexate, Motexafin gadolinium,
Mycophenolic Acid

NSC 366140

O(6)-benzylguanine, Octreotide, Oxaliplatin

Paclitaxel

Resveratrol

Sirolimus, Sorafenib, SU 5416, Suberoylanilide hydroxamic acid,
Sunitinib

Tamoxifen, Taxane, Temozolomide, Thalidomide, Tipifarnib, Treosulfan

Vinblastine, Vincristine, Vindesine, Vinorelbine

7-hydroxystaurosporine, 9-nitrocamptothecin



Info : InTextoResearch, Baelen, Wallonie (Wallonia), Belgique
(Belgium) (Marc Lacroix) & Agence Wallonne d’Information Scientifique
(AWIS)